Search

Author/Creator Kooreman, L.

1. Complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis. (November 2022)

Authors:
Ploumen, R.; Claassens, E.; Kooreman, L.; Keymeulen, K.; van Kats, M.; Gommers, S.; Siesling, S.; van Nijnatten, T.; Smidt, M.
Journal:
European journal of cancer
Issue:
Volume 175(2022)Supplement 1
Page Start:
S1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Positive association between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy. (April 2018)

Authors:
Samiei, S.; Van Nijnatten, T.; De Munck, L.; Keymeulen, K.; Simons, J.; Kooreman, L.; Siesling, S.; Lobbes, M.; Smidt, M.
Journal:
European journal of cancer
Issue:
Volume 92(2018)Supplement 3
Page Start:
S100
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial. Issue 1 (December 2017)

Authors:
Koeneman, M.; Kruse, A.; Kooreman, L.; zur Hausen, A.; Hopman, A.; Sep, S.; Van Gorp, T.; Slangen, B.; van Beekhuizen, H.; van de Sande, A.; Gerestein, C.; Nijman, H.; Kruitwagen, R.
Journal:
BMC cancer
Issue:
Volume 17:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial. Issue 1 (December 2016)

Authors:
Koeneman, M.; Kruse, A.; Kooreman, L.; zur Hausen, A.; Hopman, A.; Sep, S.; Van Gorp, T.; Slangen, B.; van Beekhuizen, H.; van de Sande, M.; Gerestein, C.; Nijman, H.; Kruitwagen, R.
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗